Tower Research Capital (TRC)’s Arcutis Biotherapeutics ARQT Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $174K | Buy |
12,414
+9,135
| +279% | +$128K | ﹤0.01% | 1916 |
|
|
2025
Q1 | $51.3K | Sell |
3,279
-10,952
| -77% | -$171K | ﹤0.01% | 2214 |
|
|
2024
Q4 | $198K | Buy |
14,231
+5,488
| +63% | +$76.4K | ﹤0.01% | 1728 |
|
|
2024
Q3 | $81.3K | Sell |
8,743
-10,177
| -54% | -$94.6K | ﹤0.01% | 2385 |
|
|
2024
Q2 | $176K | Buy |
18,920
+16,532
| +692% | +$154K | ﹤0.01% | 2176 |
|
|
2024
Q1 | $23.7K | Sell |
2,388
-2,031
| -46% | -$20.1K | ﹤0.01% | 2846 |
|
|
2023
Q4 | $14.3K | Buy |
4,419
+556
| +14% | +$1.8K | ﹤0.01% | 3898 |
|
|
2023
Q3 | $20.5K | Sell |
3,863
-8,128
| -68% | -$43.2K | ﹤0.01% | 3348 |
|
|
2023
Q2 | $114K | Buy |
11,991
+9,367
| +357% | +$89.3K | ﹤0.01% | 1924 |
|
|
2023
Q1 | $29K | Sell |
2,624
-6,241
| -70% | -$69K | ﹤0.01% | 3015 |
|
|
2022
Q4 | $131K | Buy |
8,865
+6,035
| +213% | +$89.2K | 0.01% | 1610 |
|
|
2022
Q3 | $54K | Sell |
2,830
-9,047
| -76% | -$173K | ﹤0.01% | 3091 |
|
|
2022
Q2 | $253K | Buy |
11,877
+11,018
| +1,283% | +$235K | 0.01% | 1608 |
|
|
2022
Q1 | $16K | Sell |
859
-940
| -52% | -$17.5K | ﹤0.01% | 3741 |
|
|
2021
Q4 | $38K | Buy |
1,799
+803
| +81% | +$17K | ﹤0.01% | 2994 |
|
|
2021
Q3 | $23K | Sell |
996
-1,860
| -65% | -$43K | ﹤0.01% | 3583 |
|
|
2021
Q2 | $78K | Buy |
2,856
+1,627
| +132% | +$44.4K | ﹤0.01% | 2625 |
|
|
2021
Q1 | $36K | Buy |
1,229
+849
| +223% | +$24.9K | ﹤0.01% | 3390 |
|
|
2020
Q4 | $11K | Sell |
380
-10,960
| -97% | -$317K | ﹤0.01% | 4243 |
|
|
2020
Q3 | $332K | Buy |
11,340
+9,756
| +616% | +$286K | ﹤0.01% | 2089 |
|
|
2020
Q2 | $48K | Buy |
1,584
+322
| +26% | +$9.76K | ﹤0.01% | 3073 |
|
|
2020
Q1 | $38K | Buy |
+1,262
| New | +$38K | ﹤0.01% | 1409 |
|